Preferred Label : polymyositis;

MeSH definition : Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9);

MeSH synonym : myositis, multiple; polymyositides; multiple myositis; myositides, multiple;

MeSH hyponym : polymyositis ossificans; polymyositis, idiopathic; Idiopathic Polymyositides; Idiopathic Polymyositis; Polymyositides, Idiopathic; Ossificans, Polymyositis;

Wikipedia link : https://en.wikipedia.org/wiki/Polymyositis;

Details


Main resources

You can consult :

Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)

http://www.cochrane.org/fr/CD003643/medicaments-qui-suppriment-ou-modifient-le-systeme-immunitaire-pour-le-traitement-de-la
2012
false
United Kingdom
France
French
meta-analysis
dermatomyositis
immunosuppressive agents
immunologic factors
treatment outcome
polymyositis
french abstract

---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=93568
2011
France
scientific and technical information
polymyositis

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-05/is_myosites_art56_avis_has_2010-05-07_16-52-37_390.pdf
http://www.has-sante.fr/portail/jcms/c_951083/immunosupresseurs-dans-le-traitement-des-myopathies-inflammatoires
2010
false
France
French
corticosteroid therapy
Rituximab
dermatomyositis
polymyositis
immunosuppressive agents
cyclophosphamide
mycophenolic acid
mycophenolic acid
isoxazoles
cyclosporine
methotrexate
antibodies, monoclonal
immunosuppressants
rare diseases
isoxazoles
antibodies, monoclonal, Murine-Derived
antibodies, monoclonal, Murine-Derived
drug information
Leflunomide

---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=732
2003
true
France
French
English
polymyositis
scientific and technical information

---
Nous contacter.
19/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.